To dissect the degree of T cell activation within the tumor, immune infiltrates in HVEM WT and HVEM KO tumors isolated from liver metastases were stained with a set of antibodies against molecules of the HVEM/BTLA/CD160 pathway as well as CD27, ICOS and CD137. This evidence concerns the gene TNFRSF9 and neoplasm.